CIK 0001739410
- Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851083789
- Phone
- +1 203-859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Fryer Jeffrey M bought 1,400 shares at $8.70 ($12,180)
- 4 Open-market buy Uden Stephen bought 10,000 shares at an average $9.85 ($98,502)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $10.35 ($103,473)
- 4 Open-market buy Fryer Jeffrey M bought 10,000 shares at an average $9.41 ($94,069)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 615,384 shares at $13.00 ($7,999,992)
- 4 Open-market buy 10% owner bought 615,384 shares at $13.00 ($7,999,992)
- 3/A Insider 3/A
- 4 Open-market buy Director bought 576,923 shares at $13.00 ($7,499,999)
- 4 Open-market buy Director bought 307,692 shares at $13.00 ($3,999,996)
- 4 Open-market buy Director bought 76,923 shares at $13.00 ($999,999)
- 4 Conversion FMR LLC acquired 1,694,388 shares (conversion)
- 4 Open-market buy 10% owner bought 806,000 shares at $13.00 ($10,478,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 7 · 132 filings